Ashton Thomas Private Wealth LLC Buys 3,649 Shares of Amdocs Limited $DOX

Key Points

• Ashton Thomas Private Wealth LLC increased its stake in Amdocs Limited by 17.4%, totaling $2.26 million with 24,578 shares owned following a purchase of 3,649 additional shares.
• Amdocs reported quarterly earnings of $1.72 per share, surpassing analysts' expectations, with revenue of $1.14 billion but showing an 8.4% year-over-year decline.
• The company declared a quarterly dividend of $0.527, yielding 2.5%, with a payout ratio of 42.80%, for shareholders of record on September 30th.

Ashton Thomas Private Wealth LLC grew its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 17.4% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 24,578 shares of the technology company's stock after purchasing an additional 3,649 shares during the quarter. Ashton Thomas Private Wealth LLC's holdings in Amdocs were worth $2,262,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of DOX. Tower Research Capital LLC TRC boosted its stake in shares of Amdocs by 55.0% during the 4th quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after acquiring an additional 208 shares in the last quarter. Jane Street Group LLC boosted its stake in shares of Amdocs by 111.9% during the 4th quarter. Jane Street Group LLC now owns 39,246 shares of the technology company's stock worth $3,341,000 after acquiring an additional 20,723 shares in the last quarter. Cetera Investment Advisers boosted its stake in shares of Amdocs by 6.0% during the 4th quarter. Cetera Investment Advisers now owns 52,568 shares of the technology company's stock worth $4,476,000 after acquiring an additional 2,961 shares in the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Amdocs during the 4th quarter worth $365,000. Finally, Ethic Inc. boosted its stake in shares of Amdocs by 54.0% during the 4th quarter. Ethic Inc. now owns 12,739 shares of the technology company's stock worth $1,085,000 after acquiring an additional 4,466 shares in the last quarter. 92.02% of the stock is owned by institutional investors.

Amdocs Stock Down 0.4%

DOX traded down $0.33 during trading on Friday, reaching $85.00. 555,419 shares of the stock traded hands, compared to its average volume of 810,267. The stock has a market cap of $9.60 billion, a price-to-earnings ratio of 17.24, a price-to-earnings-growth ratio of 1.56 and a beta of 0.54. Amdocs Limited has a fifty-two week low of $78.61 and a fifty-two week high of $95.41. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 1.22. The stock's 50-day simple moving average is $87.18 and its two-hundred day simple moving average is $88.54.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same quarter in the prior year, the firm posted $1.62 EPS. The firm's revenue for the quarter was down 8.4% on a year-over-year basis. As a group, equities research analysts expect that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, September 30th. Amdocs's payout ratio is currently 42.80%.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Wolfe Research assumed coverage on Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating for the company. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Amdocs has a consensus rating of "Buy" and a consensus price target of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.